Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Medical Oncology
•
Fertility Preservation
•
Breast Cancer, Non-metastatic
What would you recommend regarding IVF in a patient with DCIS on tamoxifen dealing with infertility?”
Related Questions
Would you discontinue or dose-reduce Tamoxifen in a patient that developed hepatic steatosis?
What are your top takeaways in Breast Cancer from ASCO 2024?
How do you approach early-stage breast cancer patients who are asking for ctDNA or tumor marker surveillance (or previously receiving these with another provider) when these are not part of the NCCN or ASCO guidelines?
What is your preferred method of surveillance after mastectomy?
Does delay to the time of lumpectomy impact your decision to omit radiation?
Do you have concerns about the generalizability of Oncotype testing/Mammaprint testing in making chemotherapy decisions for non-Caucasian women?
Do you follow LFTs in patients on tamoxifen as suggested in the prescribing guidelines?
With the recent FDA approval of adjuvant ribociclib, how are you deciding between ribociclib and abemaciclib for high risk HR+/HER2− early breast cancer?
Would you offer adjuvant chemotherapy to a premenopausal woman with HR+ HER2 negative IDC, T1cN0, with isolated tumor cells, oncotype RS 20, grade 2, with multifocal LVI?
Is there any definitive contraindication to use tamoxifen in patients with a brain aneurysm that is being monitored?
